Skip to main content
. 2023 Sep 30;20(3):810–821. doi: 10.14245/ns.2346430.215

Table 5.

Comparison of factors affecting patient outcomes

Variable Improved (n = 19) Not-improved (n = 10) All (n = 29) p-value
Age (yr) 50.8 ± 9.1 34.4 ± 16.5 45.7 ± 14.3 0.009
Sex 0.914
Female 8 (42.1) 4 (40.0) 12 (41.4)
Male 11 (57.9) 6 (60.0) 17 (58.6)
Location 0.624
Cervical 9 (47.4) 3 (30.0) 12 (41.4)
Thoracic 8 (42.1) 7 (70.0) 15 (51.7)
Cervicomedullary junction 2 (10.5) 0 (0) 2 (6.9)
Size (mm) 9.8 ± 4.2 9.9 ± 4.4 9.7 ± 4.2 0.926
Symptom type 0.128
Pain 4 (21.1) 0 (0) 4 (13.8)
Weakness 4 (21.1) 0 (0) 4 (13.8)
Sensory deficits 3 (15.8) 2 (20.0) 5 (17.2)
Gait disturbance 2 (10.5) 3 (30.0) 5 (17.2)
Bowel/bladder dysfunction 6 (31.6) 5 (50.0) 11 (37.9)
Symptom duration (mo) 30.1 (49.1) 11.9 (22.4) 23.8 (42.3) 0.015
Clinical course prior to presentation 0.003
A 4 (21.1) 8 (80.0) 12 (41.4)
C 13 (68.4) 2(20.0) 15 (51.7)
M 2 (10.5) 0 (0) 2 (6.9)
MMcS on presentation 0.035
1 3 (15.8) 1 (10.0) 4 (13.8)
2 9 (47.4) 1 (10.0) 10 (34.5)
3 5 (26.3) 3 (30.0) 8 (27.6)
4 0 (0) 3 (30.0) 3 (10.3)
5 2 (10.5) 2 (20.0) 4 (13.8)
Prior hemorrhage by history 0.530
No 8 (42.1) 3 (30.0) 11 (37.9)
Yes 11 (57.9) 7 (70.0) 18 (62.1)
Recurrent hemorrhages by history 0.016
No 16 (84.2) 4 (40.0) 20 (69.0)
Yes 3 (15.8) 6 (60.0) 9 (31.0)

Values are presented as mean±standard deviation or number (%).

MMcS, modified McCormick scale.